Get access

Psychogenic movement disorder mimicking RLS: A case report

Authors


  • Potential conflict of interest: M. Lanz received honoraria from Boehringer Ingelheim and Hoffmann La Roche. J. Steinig received honoraria from Boehringer Ingelheim. H. Haack reports no disclosures. S. Happe received honoraria from Boehringer Ingelheim, Hoffmann La Roche, and Pfizer and takes part in clinical studies from Axxonis Pharma, Essex Pharma, Glaxo Smith Kline, Organon, Sanofi Aventis, Schwarz Pharma, UCB Pharma.

No abstract is available for this article.

Get access to the full text of this article

Ancillary